Authors
Latest:
EyeCon 2023: Pearls for monitoring intraocular pressure at home and in the officeReal-time insights into fluctuations enhance glaucoma care and understanding of vision risk.
Latest:
Viewing ptosis through a biopsychosocial lensLow-lying lids affect much more than patients' visual field, with implications for visual quality and their self-esteem.
Latest:
Addressing symptom relief of optic neuritis in multiple sclerosisContoured prism lenses may resolve symptoms such as neck, shoulder, and head pain.
Latest:
Tackling the problem of contact lens dropout from presbyopiaWith advanced, easy-to-fit multifocal lens technologies, patients don’t need to compromise
Latest:
ARVO 2024: Understanding the pharmacokinetics of latanoprost and prednisolone acetate with perfluorohexyloctaneThe rabbit model found that the levels of the active metabolites were very comparable, whether or not eyes had received a prior installation of perfluorohexyloctane.
Latest:
Sight Sciences' fair access campaign aims for insured access to heat and expression therapy for meibomian gland dysfunctionJim Sluck, VP of Marketing for Sight Sciences' TearCare, shares the impetus behind the company's fair access campaign.
Latest:
Impact of vision impairment on children’s mental healthStudies conducted with Orbis International conclude positive mental health and academic improvements of children provided appropriate eye care and glasses, filling important research gaps and providing essential guidance for future interventions and research.
Latest:
NOA 2023: Insights and lessons from a pediatric patient caseAt NOA 2023 in Fort Lauderdale, Florida, Rhea Magee, OD, presented a pediatric patient case as part of the Resident Grand Rounds.
Latest:
Basic and beyond: technology for every level of scleral lens managementHow to fit lenses with simple devices and when to expand your armature.
Latest:
ASCRS 2023: Aurion clinical trials of endothelial cell therapy injectionJohn Berdahl, MD, discussed the Aurion clinical trials of endothelial cell therapy injection at the 2023 ASCRS annual meeting in San Diego.
Latest:
AAOpt 2023: Raising awareness for vision healthOptometry Times sat down with Carla Calizaire, Global Leader of Diversity Inclusion for Johnson and Johnson Med Tech to go in depth about the Vision Made Possible and Sight for Kids campaign.
Latest:
EyeCon 2024: Myopia interventions across the lifespanAdam S. Wenick, MD, PhD, discussed myopia interventions across the lifespan at EyeCon 2024, covering treatments, complications, and prevention strategies.
Latest:
Ocular Therapeutix randomizes more than 300 patients in SOL-1 Phase 3 trial for OTX-TKIThe trial is expected to close randomization in early December 2024.
Latest:
AAOpt 2024: Dry eye for $1000, Dr Lisa HornickLisa Hornick, OD, MBA, FAAO, brought a twist to Jeopardy with her interactive talk at AAOpt 2024 titled "Dry Eye Jeopardy Returns."
Latest:
AAOpt 2022: CHAMP study shows positive top-line results for treating myopiaThe CHAMP phase 3 study shows strong safety and efficacy of NVK002 for the treatment of myopia.
Latest:
The complicated ins and outs of pediatric glaucomaPediatric glaucoma, although rare, can cause irreversible vision loss and leave children visually impaired if not treated timely and adequately.
Latest:
How diabetes and glaucoma intersectConsider the impact of diabetes on management of patients with glaucoma
Latest:
Offer advanced patient care by bundling servicesCombining products and resources in creative ways can help grow your business.
Latest:
Meeting the need: Screening parameters for presbyopia-correcting dropsDoctors should consider a few key points before writing a prescription.
Latest:
Handling comorbidities prior to surgeryAddressing issues prior to referral will facilitate the referral process and enable more efficient care for your patient as well as maximize outcomes.
Latest:
Is complement therapy the path forward for geographic atrophy?Clinical benefit of complement inhibition has been demonstrated in clinical trials, but there are possible consequences to consider.
Latest:
Expanding the treatment arsenal in glaucoma managementIn this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients.
Latest:
Transcript: Tips on fitting new Johnson & Johnson Vision multifocal contact lensTwo key points to remember when fitting
Latest:
2024 in the rearview: What was the biggest development in optometry this year?A few optometrists share which innovations in optometry they were most excited about in 2024.
Latest:
Adjunct role for Dextenza insert in allergic conjunctivitis?Regarding both the amount and speed of symptom improvement, patients were more satisfied with the insert compared with the topical steroid, but there was no statistically significant difference vs the topical antihistamine in terms of satisfaction.
Latest:
ASCRS 2023: Wills Eye Hospital research on corneal swelling and dynamics during corneal collagen crosslinkingZeba Syed, MD, from Wills Eye Hospital discussed their research on corneal swelling and dynamics during corneal collagen crosslinking at the 2023 ASCRS annual meeting in San Diego.
Latest:
Heru advances visual field assessmentsNew platform has potential to overcome challenges of legacy technology
